Hansenula anomala fungemia

Eliane Baron; Elias Anaissie; Frank Dumphy; Kenneth McCredie; Victor Fainstein

doi:10.1093/clinids/10.6.1182

Hansenula anomala fungemia

Eliane Baron, Elias Anaissie, Frank Dumphy, Kenneth McCredie, Victor Fainstein

Research output: Contribution to journal › Article › peer-review

63 Scopus citations

Abstract

Fungi of the genus Hansenula have rarely been reported as pathogenic in humans. A case of catheter-related Hansenula anomala fungemia in a patient with acute leukemia in remission is presented, and the clinical features of 11 additional patients infected with Hansenula species are reviewed. The spectrum of disease with these organisms ranges from asymptomatic fungemia to life-threatening disseminated infection. Predisposing factors appear to be immunosuppression, use of intravenous devices, and previous treatment with antibacterial drugs. Clinical experience and limited in vitro susceptibility data show that amphotericin B remains the drug of choice in the treatment of hansenula infections.

Original language	English (US)
Pages (from-to)	1182-1186
Number of pages	5
Journal	Clinical Infectious Diseases
Volume	10
Issue number	6
DOIs	https://doi.org/10.1093/clinids/10.6.1182
State	Published - Nov 1988

ASJC Scopus subject areas

Microbiology (medical)
Infectious Diseases

Access to Document

10.1093/clinids/10.6.1182

Cite this

@article{91afc218bda0481fb87f1de4ceb8edf7,

title = "Hansenula anomala fungemia",

abstract = "Fungi of the genus Hansenula have rarely been reported as pathogenic in humans. A case of catheter-related Hansenula anomala fungemia in a patient with acute leukemia in remission is presented, and the clinical features of 11 additional patients infected with Hansenula species are reviewed. The spectrum of disease with these organisms ranges from asymptomatic fungemia to life-threatening disseminated infection. Predisposing factors appear to be immunosuppression, use of intravenous devices, and previous treatment with antibacterial drugs. Clinical experience and limited in vitro susceptibility data show that amphotericin B remains the drug of choice in the treatment of hansenula infections.",

author = "Eliane Baron and Elias Anaissie and Frank Dumphy and Kenneth McCredie and Victor Fainstein",

year = "1988",

month = nov,

doi = "10.1093/clinids/10.6.1182",

language = "English (US)",

volume = "10",

pages = "1182--1186",

journal = "Clinical Infectious Diseases",

issn = "1058-4838",

publisher = "Oxford University Press",

number = "6",

}

TY - JOUR

T1 - Hansenula anomala fungemia

AU - Baron, Eliane

AU - Anaissie, Elias

AU - Dumphy, Frank

AU - McCredie, Kenneth

AU - Fainstein, Victor

PY - 1988/11

Y1 - 1988/11

N2 - Fungi of the genus Hansenula have rarely been reported as pathogenic in humans. A case of catheter-related Hansenula anomala fungemia in a patient with acute leukemia in remission is presented, and the clinical features of 11 additional patients infected with Hansenula species are reviewed. The spectrum of disease with these organisms ranges from asymptomatic fungemia to life-threatening disseminated infection. Predisposing factors appear to be immunosuppression, use of intravenous devices, and previous treatment with antibacterial drugs. Clinical experience and limited in vitro susceptibility data show that amphotericin B remains the drug of choice in the treatment of hansenula infections.

AB - Fungi of the genus Hansenula have rarely been reported as pathogenic in humans. A case of catheter-related Hansenula anomala fungemia in a patient with acute leukemia in remission is presented, and the clinical features of 11 additional patients infected with Hansenula species are reviewed. The spectrum of disease with these organisms ranges from asymptomatic fungemia to life-threatening disseminated infection. Predisposing factors appear to be immunosuppression, use of intravenous devices, and previous treatment with antibacterial drugs. Clinical experience and limited in vitro susceptibility data show that amphotericin B remains the drug of choice in the treatment of hansenula infections.

UR - http://www.scopus.com/inward/record.url?scp=0024117527&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0024117527&partnerID=8YFLogxK

U2 - 10.1093/clinids/10.6.1182

DO - 10.1093/clinids/10.6.1182

M3 - Article

C2 - 3060946

AN - SCOPUS:0024117527

SN - 1058-4838

VL - 10

SP - 1182

EP - 1186

JO - Clinical Infectious Diseases

JF - Clinical Infectious Diseases

IS - 6

ER -

Hansenula anomala fungemia

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this